Pharma
Progress
A new virtual event from BresMed and Cello Health
Embedding patient journeys into clinical and commercial planning, for more focused decisions and improved patient outcomes
Wednesday, 21st April 2021
Two-hour event starts 08:00 New York / 13:00 London / 14:00 Zürich
- Attendance open to commercial and insight professionals in the healthcare and pharma industry
- Listen to inspiring patient, agency and market-leading, pharma-side speakers as they share their insights and experience
- Live Q&A - pose your own questions and comment via the live chat function
"BresMed and Cello Health are delighted to host a new joint global Pharma Progress conference. The first in a series of virtually enabled, short and focused events dedicated to highlighting some of healthcare's most imperative challenges and discussing the most relevant innovative solutions to address them."
Event overview
Increasingly a mainstay of clinical and commercial planning, we explore how the patient journey is influencing decision making in pharma, whether the patient voice is being clearly represented and how this is impacting patient outcomes. At a time when there are intense healthcare challenges and a reprioritization of health budgets, we also look at whether COVID-19 has fundamentally changed the patient journey, and the implications for pharma.
Attendees will hear about
- The needs of patients in complex markets, and how the patient voice is being interpreted
- How the patient voice can impact commercial decision making
- How COVID-19 is impacting the patient journey and implications for pharma
Agenda
Two-hour event starts 08:00 New York / 13:00 London / 14:00 Zürich
Introduction and Overview
20 mins
Hearing the patient voice: are we really listening?
Chair, Patient and Public Voices Forum, NHS England Cancer Programme; Director of Partnerships and Evaluation, Shine.
Starting with patients in mind - how do they feel their needs are being heard? What is working well and how pharma and healthcare can improve.
30 mins
Journey into the unknown: does the patient journey inform better strategy and enhance patient outcomes?
Patient Engagement & Advocacy Lead, Europe, Middle-East and Africa, Janssen.
Head of EMEA Marketing & Operations at Novartis Gene Therapies, Novartis.
How the patient journey and voice are finding new meaning in pharma. We explore the challenges and opportunities from the perspective of two leading pharma companies.
10 mins
Break
25 mins
Has COVID-19 fundamentally changed the patient journey?
President, Patient Insights, Cello Health.
Emerging trends in how COVID-19 is impacting patient journeys and implications for pharma.
15 mins
Q&A
Opportunity for attendees to ask questions directly to speakers and panellists.
Close
